Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Muctarr Sesay
Advertisement
Muctarr Sesay, PhD, is chief scientific officer and vice-president of Bioconjugation at Goodwin Biotechnology.
Articles by Muctarr Sesay
Bioconjugation chemistry is the joining of biomolecules to other biomolecules, small molecules, and polymers by chemical or biological means.
Advertisement
Latest Updated Articles
Monoclonal Antibody Conjugation via Chemical ModificationPublished: December 1st 2003 | Updated:
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
AstraZeneca Next to Agree to MFN Deal: Report
2
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
3
Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part II. Biopharmaceutical Non-Sterile Equipment Cleaning
4
BioPharm Weekly News Roundup—Week of Oct. 6, 2025
5
